2025 RTP Information 2025 RTP InformationADAMS InformationADAMS & ATHLETE CENTRAL APP User Information v2WADA ADAMS AppWADA Q&A's - Whereabouts and Atlete Central AppAdvisories on Use of Certain Medications and MethodsAsthma and ADHD AdvisoryCBD and THC Position StatementIV AdvisoryTramadol AdvisoryAthlete Education Overview & ResourcesAthlete Support Personnel Guide to the 2021 CodeDangers-of-Doping-Leaflet-1International Standard for Education 2021Quick OVERVIEW of Anti-Doping 2021TUE - At-a-glance 2021Whereabouts Info Leaflet 2021Blood Sample Collection and Athlete Biological Passport GuidelinesGuidelines for Sample Collection 2023guidelines_abp_v9_2023_finalContact Details-SA Institute for Drug-Free SportSAIDS Contact DetailsOnline Medication Check Tools and AppsAccess to online medication check Tools & Apps v3SAIDS Anti-Doping Rules and World Anti-Doping Code2021_world anti-doping codeAnnexure A-Who Needs to Apply for a TUE in AdvanceSAIDS Anti-Doping Rules 2021SAIDS RTP Whereabouts Failure PolicyArticle 4.8 Collecting Whereabouts Requirements and 4.9 Coordinating with other Anti-Doping Organizations_2023 ISTIArticle B.3 Results Management for a Potential Whereabouts Failure_2023 ISRMInternational Standard Results Management 2023SAIDS RTP Whereabouts Failure Policy_Version 10Supplements InformationSupplements under the spotlight leafletBokSmart-Practical-Nutrition-for-Rugby-1Drug-Induced-Liver-Injury-Associated-With-RAD-140 products-and-LGD-4033Intentional-or-unintentional-doping - Role-of-SupplementsIOC-Expert Panel Statement-on-Dietary-Supplements-and-Elite-AthletesIOC-Nutrition-for-Athletes BookletLigandrol-LGD-4033-Induced-Liver-InjurySAIDS Supplements LeafletTesting InformationGuidelines for Sample Collection 2023International Standard - Testing and Investigations 2023Link to SAIDS TESTING Web page & INFOTherapeutic Use Exemption InformationAnnexure A-Who Needs to Apply for a TUE in Advanceglucocorticoids_and_therapeutic_use_exemptions_11_november_2023International Standard for Therapeutic Use Exemptions 2023istue_guidelines_2023_enSAIDS TUE Form_click to editSAIDS TUE Form_without click to editTUE - At-a-glance 2021WADA Prohibited List Information2024 Prohibited List - Tramadol Factsheet Athletes and ASP_FINAL_2023_ENG2024 Prohibited List - Tramadol Factsheet for Medical Professionals_FINAL_2023_ENG2024 Prohibited List - WADA Monitoring Program - 20242024 Prohibited List - WADA Prohibited List - January 20242024 Prohibited List - WADA Prohibited List - Summary of Modifications - 20242025 Prohibited List - 2025 WADA Prohibited List2025 Prohibited List - 2025_list_explanatory_note_en_final_11_september_20242025 Prohibited List - 2025_list_monitoring_program_en_final_clean_11_september_2024Whereabouts InformationADAMS User Information v2Article 4.8 Collecting Whereabouts Requirements and 4.9 Coordinating with other Anti-Doping Organizations_2023 ISTIArticle B.3 Results Management for a Potential Whereabouts Failure_2023 ISRMWADA Frequently Asked Q&As - Whereabouts & Athlete Central AppWhereabouts Info Leaflet 2021